262 related articles for article (PubMed ID: 33060142)
21. Unrecognized peripartum cardiomyopathy in Haitian women.
Fett JD; Christie LG; Carraway RD; Ansari AA; Sundstrom JB; Murphy JG
Int J Gynaecol Obstet; 2005 Aug; 90(2):161-6. PubMed ID: 15961090
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and outcomes of pregnant women with cardiomyopathy stratified by etiologies: A population-based study.
Phan D; Duan L; Ng A; Shen AY; Lee MS
Int J Cardiol; 2020 Apr; 305():87-91. PubMed ID: 31889561
[TBL] [Abstract][Full Text] [Related]
23. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
[TBL] [Abstract][Full Text] [Related]
24. An update on treatments and outcomes in peripartum cardiomyopathy.
Sheppard R; Rajagopalan N; Safirstein J; Briller J
Future Cardiol; 2014 May; 10(3):435-47. PubMed ID: 24976479
[TBL] [Abstract][Full Text] [Related]
25. Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis.
Kumar A; Ravi R; Sivakumar RK; Chidambaram V; Majella MG; Sinha S; Adamo L; Lau ES; Al'Aref SJ; Asnani A; Sharma G; Mehta JL
Curr Probl Cardiol; 2023 Feb; 48(2):101461. PubMed ID: 36261102
[TBL] [Abstract][Full Text] [Related]
26. Association of autoantibodies against the M2-muscarinic receptor with long-term outcomes in peripartum cardiomyopathy patients: A 5-year prospective study.
Ma G; Wang Y; Hou D; Liu J; Zhang J; Xu L; Wang H; Zhao W; Zhang Y; Zhang L
J Cardiol; 2019 Sep; 74(3):251-257. PubMed ID: 30878354
[TBL] [Abstract][Full Text] [Related]
27. Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study.
Behrens I; Basit S; Lykke JA; Ranthe MF; Wohlfahrt J; Bundgaard H; Melbye M; Boyd HA
PLoS One; 2019; 14(2):e0211857. PubMed ID: 30785920
[TBL] [Abstract][Full Text] [Related]
28. Proteomic Profiling in Patients With Peripartum Cardiomyopathy: A Biomarker Study of the ESC EORP PPCM Registry.
Kodogo V; Viljoen C; Hoevelmann J; Chakafana G; Tromp J; Farhan HA; Goland S; van der Meer P; Karaye K; Kryczka K; Hilfiker-Kleiner D; Jackson A; Mebazaa A; Böhm M; Pieske B; Bauersachs J; Bell L; Sliwa K;
JACC Heart Fail; 2023 Dec; 11(12):1708-1725. PubMed ID: 37804308
[TBL] [Abstract][Full Text] [Related]
29. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy.
Kao DP; Hsich E; Lindenfeld J
JACC Heart Fail; 2013 Oct; 1(5):409-16. PubMed ID: 24163791
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and predictors of right ventricular diastolic dysfunction in peripartum cardiomyopathy.
Karaye KM; Lindmark K; Henein MY
J Echocardiogr; 2017 Sep; 15(3):135-140. PubMed ID: 28247237
[TBL] [Abstract][Full Text] [Related]
31. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
Hilfiker-Kleiner D; Struman I; Hoch M; Podewski E; Sliwa K
Curr Heart Fail Rep; 2012 Sep; 9(3):174-82. PubMed ID: 22729360
[TBL] [Abstract][Full Text] [Related]
32. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.
Bello N; Rendon ISH; Arany Z
J Am Coll Cardiol; 2013 Oct; 62(18):1715-1723. PubMed ID: 24013055
[TBL] [Abstract][Full Text] [Related]
33. Pre-pregnancy obesity and the risk of peripartum cardiomyopathy: A systematic review and meta-analysis.
Putra ICS; Irianto CB; Raffaello WM; Suciadi LP; Prameswari HS
Indian Heart J; 2022; 74(3):235-238. PubMed ID: 35490847
[TBL] [Abstract][Full Text] [Related]
34. Peripartum cardiomyopathy unveiled: Etiology, diagnosis, and therapeutic insights.
Safira A; Tjahjadi AK; Adytia GJ; Waitupu A; Sutanto H
Curr Probl Cardiol; 2024 May; 49(5):102474. PubMed ID: 38395115
[TBL] [Abstract][Full Text] [Related]
35. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy-.
Kamiya CA; Kitakaze M; Ishibashi-Ueda H; Nakatani S; Murohara T; Tomoike H; Ikeda T
Circ J; 2011; 75(8):1975-81. PubMed ID: 21617320
[TBL] [Abstract][Full Text] [Related]
36. Peripartum cardiomyopathy: a challenge for cardiologist.
Aursulesei V
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):358-67. PubMed ID: 24340517
[TBL] [Abstract][Full Text] [Related]
37. Rapid recovery from peripartum cardiomyopathy after inhibition of prolactin.
Lucreziotti S; Belletti S; Massironi L; Lombardi F
Int J Cardiol; 2011 Sep; 151(3):e105-6. PubMed ID: 20934224
[No Abstract] [Full Text] [Related]
38. Disparities in death rates in women with peripartum cardiomyopathy between advanced and developing countries: A systematic review and meta-analysis.
Kerpen K; Koutrolou-Sotiropoulou P; Zhu C; Yang J; Lyon JA; Lima FV; Stergiopoulos K
Arch Cardiovasc Dis; 2019 Mar; 112(3):187-198. PubMed ID: 30594574
[TBL] [Abstract][Full Text] [Related]
39. Prolactin: a new therapeutic target in peripartum cardiomyopathy.
Yamac H; Bultmann I; Sliwa K; Hilfiker-Kleiner D
Heart; 2010 Sep; 96(17):1352-7. PubMed ID: 20657009
[TBL] [Abstract][Full Text] [Related]
40. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution.
Fett JD; Christie LG; Carraway RD; Murphy JG
Mayo Clin Proc; 2005 Dec; 80(12):1602-6. PubMed ID: 16342653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
